SUNLIGHT GROUP PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: N85051 | WIRRAL, CH62 5HS
Showing results 501-550 of 744
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Calcium acetate | 36 | 3,066 | £273 | +94.5% ▲ |
| Liquid paraffin | 36 | 17.8K | £118 | +418.9% ▲ |
| 36 | 7,020 | £261 | -64.6% ▼ | |
| Azelastine hydrochloride | 35 | 280 | £213 | +194.4% ▲ |
| Carmellose sodium | 35 | 3,930 | £564 | -46.0% ▼ |
| 35 | 1,030 | £597 | +34.3% ▲ | |
| Codeine phosphate | 34 | 12.2K | £239 | +136.9% ▲ |
| Pivmecillinam hydrochloride | 34 | 465 | £246 | -35.2% ▼ |
| Erythromycin ethylsuccinate | 34 | 6,060 | £643 | +45.6% ▲ |
| Ciprofloxain/dexameth | 34 | 195 | £227 | +10.7% ▲ |
| Benzalkonium chloride | 34 | 8,500 | £189 | +196.4% ▲ |
| 34 | 720 | £179 | +131.1% ▲ | |
| Linaclotide | 33 | 924 | £1.2K | +80.6% ▲ |
| Clonidine hydrochloride | 33 | 1,624 | £128 | +80.6% ▲ |
| Captopril | 33 | 1,848 | £549 | +128.0% ▲ |
| Denosumab | 33 | 33 | £6.1K | +21.3% ▲ |
| Sevelamer | 33 | 10.8K | £1.8K | +50.6% ▲ |
| 33 | 33 | £78 | +1.8% vs avg | |
| 33 | 60 | £403 | +63.2% ▲ | |
| Phosphates (Rectal) | 32 | 298 | £2.0K | +161.8% ▲ |
| Levomepromazine maleate | 32 | 749 | £731 | +248.4% ▲ |
| Lofepramine hydrochloride | 32 | 2,451 | £1.1K | +7.0% ▲ |
| Fluvoxamine maleate | 32 | 835 | £381 | +163.2% ▲ |
| Varenicline tartrate | 32 | 956 | £1.1K | +223.2% ▲ |
| Ciclosporin | 32 | 1,796 | £2.9K | +91.7% ▲ |
| 32 | 2,000 | £349 | +65.5% ▲ | |
| 32 | 2,005 | £592 | -60.2% ▼ | |
| Estradiol valerate | 31 | 2,716 | £227 | +58.7% ▲ |
| Sodium chloride | 31 | 487 | £156 | +271.1% ▲ |
| Trimipramine maleate | 30 | 1,372 | £6.4K | +88.3% ▲ |
| Exenatide | 30 | 120 | £2.2K | +71.1% ▲ |
| Tafluprost and timolol | 30 | 900 | £435 | +56.3% ▲ |
| Medicated stockings | 30 | 304 | £1.1K | +345.2% ▲ |
| Bupropion hydrochloride | 29 | 1,026 | £681 | +168.3% ▲ |
| Betamethasone sodium phosphate | 29 | 1,821 | £241 | +135.9% ▲ |
| Combined ethinylestradiol 35mcg | 29 | 2,142 | £136 | +132.8% ▲ |
| Powder extensively hydrolysed formula (0913132) | 29 | 66.4K | £2.1K | +416.0% ▲ |
| 29 | 570 | £1.4K | +84.8% ▲ | |
| Inclisiran | 28 | 28 | £1.4K | +122.3% ▲ |
| Levocetirizine | 28 | 2,170 | £282 | +79.7% ▲ |
| Amantadine hydrochloride | 28 | 1,428 | £352 | +0.5% vs avg |
| Glimepiride | 28 | 1,704 | £51 | -69.7% ▼ |
| Sodium feredetate | 28 | 11.8K | £337 | -2.2% ▼ |
| Olmesartan medoxomil | 27 | 756 | £27 | -60.8% ▼ |
| Omega-3-acid ethyl esters | 27 | 2,268 | £1.0K | +27.8% ▲ |
| Indacaterol/glycopyrronium | 27 | 810 | £834 | -40.2% ▼ |
| Azelastine hydrochloride | 27 | 616 | £280 | +140.9% ▲ |
| Adapalene | 27 | 1,215 | £422 | +23.4% ▲ |
| 27 | 89 | £977 | +166.0% ▲ | |
| 27 | 147 | £268 | +63.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.